1 01, 2016 Ferhat Gürkan Aslan et al., [Investigation of human papillomavirus prevalence in women in Eski?ehir, Turkey by Pap smear, hybrid capture 2 test and consensus real-time polymerase chain reaction and typing with pyrosequencing method]. Mikrobiyoloji Bulteni Diatech Pharmacogenetics2017-08-25T11:28:51+02:00 Leggi di più
21 12, 2015 Nora Sahnane et al., Aberrant DNA methylation profiles of inherited and sporadic colorectal cancer. Clinical Epigenetics Diatech Pharmacogenetics2017-08-08T12:34:05+02:00 Leggi di più
1 12, 2015 Sara Franceschi et al., Investigating molecular alterations to profile short- and long-term recurrence-free survival in patients with primary glioblastoma. Oncology Letters Diatech Pharmacogenetics2017-08-08T12:33:20+02:00 Leggi di più
1 12, 2015 Caterina Chiappetta et al., Evaluation of the management of Hr-HPV+/PapTest- women: Results at 1-year recall. International Journal of Clinical and Experimental Pathology Diatech Pharmacogenetics2017-08-08T12:34:57+02:00 Leggi di più
19 11, 2015 Elena Doldo et al., High expression of cellular retinol binding protein-1 in lung adenocarcinoma is associated with poor prognosis. Genes & Cancer Diatech Pharmacogenetics2017-08-07T17:16:05+02:00 Leggi di più
19 11, 2015 Federica Panebianco et al., The combination of four molecular markers improves thyroid cancer cytologic diagnosis and patient management. BMC Cancer Diatech Pharmacogenetics2017-08-08T12:32:26+02:00 Leggi di più
17 11, 2015 Michel P. Bihl et al., Human Papillomavirus (HPV) Detection in Cytologic Specimens: Similarities and Differences of Available Methodology. Applied Immunohistochemistry & Molecular Morphology Diatech Pharmacogenetics2017-08-08T09:02:28+02:00 Leggi di più
5 11, 2015 Laura Capelli et al., Role of BRAF molecular analysis in the management of papillary thyroid carcinoma: analysis of cytological and histological samples. Cytopathology Diatech Pharmacogenetics2017-08-08T09:06:46+02:00 Leggi di più
15 09, 2015 Matteo Landriscina et al., RAS/BRAF mutational status in familial non-medullary thyroid carcinomas: A retrospective study. Oncology Letters Diatech Pharmacogenetics2017-08-08T12:29:23+02:00 Leggi di più
15 09, 2015 Valentina Guarneri et al., Prospective Biomarker Analysis of the Randomized CHER-LOB Study Evaluating the Dual Anti-HER2 Treatment With Trastuzumab and Lapatinib Plus Chemotherapy as Neoadjuvant Therapy for HER2-Positive Breast Cancer. The Oncologist Diatech Pharmacogenetics2017-08-08T09:48:41+02:00 Leggi di più
